Nearly half of melanomas harbor mutations of the v-raf murine sarcoma viral oncogene homolog B (BRAF) gene, leading to activation of the mitogen-activated protein kinase (MAPK) signaling pathway4. This evidence concerns the gene BRAF and melanoma.